These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 22542492)
81. Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence. Villas-Boas GR; Lavorato SN; Paes MM; de Carvalho PMG; Rescia VC; Cunha MS; de Magalhães-Filho MF; Ponsoni LF; de Carvalho AAV; de Lacerda RB; da S Leite L; da S Tavares-Henriques M; Lopes LAF; Oliveira LGR; Silva-Filho SE; da Silveira APS; Cuman RKN; de S Silva-Comar FM; Comar JF; do A Brasileiro L; Dos Santos JN; de Freitas WR; Leão KV; da Silva JG; Klein RC; Klein MHF; da S Ramos BH; Fernandes CKC; de L Ribas DG; Oesterreich SA Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33673205 [TBL] [Abstract][Full Text] [Related]
82. The Roles of Serotonin in Neuropsychiatric Disorders. Pourhamzeh M; Moravej FG; Arabi M; Shahriari E; Mehrabi S; Ward R; Ahadi R; Joghataei MT Cell Mol Neurobiol; 2022 Aug; 42(6):1671-1692. PubMed ID: 33651238 [TBL] [Abstract][Full Text] [Related]
83. Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects. Ohno Y; Kunisawa N; Shimizu S Front Pharmacol; 2019; 10():1045. PubMed ID: 31607910 [TBL] [Abstract][Full Text] [Related]
84. Synergistic anticataleptic effect of imipramine and nicotine in a rotenone-induced rat model. Ionov ID; Pushinskaya II; Gorev NP; Shpilevaya LA Psychopharmacology (Berl); 2019 Nov; 236(11):3125-3133. PubMed ID: 31069424 [TBL] [Abstract][Full Text] [Related]
85. Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics. Ribeiro SB; de Araújo AA; Medeiros CA; Chaves KM; Alves MD; Oliveira AG; Martins RR Eur J Clin Pharmacol; 2017 Mar; 73(3):351-355. PubMed ID: 27889833 [TBL] [Abstract][Full Text] [Related]
86. Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia. Terevnikov V; Joffe G; Stenberg JH Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25991654 [TBL] [Abstract][Full Text] [Related]
87. Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. Podurgiel SJ; Milligan MN; Yohn SE; Purcell LJ; Contreras-Mora HM; Correa M; Salamone JD Neuropsychopharmacology; 2015 Aug; 40(9):2240-7. PubMed ID: 25759301 [TBL] [Abstract][Full Text] [Related]
88. Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration. Aristieta A; Morera-Herreras T; Ruiz-Ortega JA; Miguelez C; Vidaurrazaga I; Arrue A; Zumarraga M; Ugedo L Psychopharmacology (Berl); 2014 May; 231(9):1913-24. PubMed ID: 24271033 [TBL] [Abstract][Full Text] [Related]
89. Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors. Shimizu S; Ohno Y Aging Dis; 2013 Feb; 4(1):1-13. PubMed ID: 23423244 [TBL] [Abstract][Full Text] [Related]
90. Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors. Ohno Y; Imaki J; Mae Y; Takahashi T; Tatara A Neuropharmacology; 2011; 60(2-3):201-8. PubMed ID: 20813116 [TBL] [Abstract][Full Text] [Related]